NEW YORK (GenomeWeb News) – DDC Medical has signed a licensing agreement with the National Institute of Standards and Technology to commercialize mouse cell line authentication using STR DNA technology, the firm announced today.

The DDC mouse cell line authentication test uses STR DNA analysis for mouse DNA characterization, and the loci that are selected produce "stable robust results based on a tetranucleotide repeat, similar to the types of loci examined for human cell line authentication," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.